処方鎮痛薬の世界市場レポート 2025年

処方鎮痛薬の市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR5.7％で972億3,000万米ドルに成長します。予測期間においては、個別化医療への需要の高まり、外傷後疼痛管理への注目の高まり、疼痛管理への遠隔医療の採用拡大、オピオイド代替薬を求める患者の増加、神経障害性疼痛の有病率の増加といった要因が成長を牽引すると予想されます。この時期の主な動向としては、オピオイド以外の代替鎮痛薬の開発、デジタルヘルスソリューションの統合、標的疼痛治療の革新、併用鎮痛薬の開発、非中毒性鎮痛薬の進歩などが挙げられます。

関節炎の有病率の増加は、処方鎮痛薬市場の拡大を促進すると予想されます。関節炎は、1つまたは複数の関節に炎症を引き起こし、痛み、腫れ、こわばり、運動能力の低下をもたらします。関節炎の有病率の上昇は、肥満が主な原因であり、過剰な体重が関節、特に膝にさらなる負担をかけ、炎症を促進するからです。処方鎮痛剤は、炎症と疼痛を軽減し、関節機能を改善し、罹患者の全体的な生活の質を高めることによって、関節炎の管理に役立ちます。例えば、2023年3月、英国を拠点とする政府部門であるOffice for Health Improvement and Disparitiesは、2022年には16歳以上の17.6％が関節炎または進行中の背中や関節の問題を抱えており、2021年の17.0％から増加していると報告しました。その結果、関節炎の有病率の増加が処方鎮痛薬市場の成長を牽引しています。

処方鎮痛薬市場の企業は、オピオイド中毒や患者の安全性に対する懸念の高まりを受けて、非オピオイド鎮痛剤などの代替療法の開発に注力しています。非オピオイド鎮痛剤は、オピオイドの中毒性リスクを伴わずに疼痛緩和を提供し、中毒や過剰摂取の可能性を低減しながら、より安全で効果的な長期疼痛管理ソリューションを提供します。例えば、2025年1月、米国のバイオテクノロジー企業であるバーテックス・ファーマシューティカルズ・インコーポレーテッドは、ファースト・イン・クラスの非オピオイド経口薬であるJOURNAVXの承認を米国食品医薬品局（FDA）から取得しました。本薬は、末梢神経のNaV1.8ナトリウムチャネルを選択的に遮断し、中枢神経系に影響を与えることなく疼痛信号を抑制することで、中毒のリスクを伴わずに効果的な急性疼痛緩和を提供します。腹部形成術と外反母趾切除術を対象とした第3相臨床試験において、1日2回の投与で臨床的に意義のある疼痛軽減効果を示しており、規制薬物には分類されていないため、より安全な急性疼痛管理のニーズに応えることができます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の処方鎮痛薬PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の処方鎮痛薬市場：成長率分析
• 世界の処方鎮痛薬市場の実績：規模と成長, 2019-2024
• 世界の処方鎮痛薬市場の予測：規模と成長, 2024-2029, 2034F
• 世界の処方鎮痛薬総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の処方鎮痛薬市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 処方箋非ステロイド性抗炎症薬
• オピオイド
• 抗てんかん薬
• 抗うつ薬
• その他のタイプ
• 世界の処方鎮痛薬市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口
• 注射剤
• 経皮
• その他の投与経路
• 世界の処方鎮痛薬市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 神経障害性疼痛
• がんの痛み
• 術後の痛み
• その他の用途
• 世界の処方鎮痛薬市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンライン薬局
• 世界の処方鎮痛薬市場、処方非ステロイド性抗炎症薬、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• COX-2阻害剤
• 従来の非ステロイド性抗炎症薬
• 非ステロイド性抗炎症薬の併用
• 世界の処方鎮痛薬市場、オピオイド、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• 強力なオピオイド
• 軽度のオピオイド
• オピオイド併用薬
• 世界の処方鎮痛薬市場、抗てんかん薬、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• ナトリウムチャネル遮断薬
• ガンマアミノ酪酸モジュレーター
• グルタミン酸阻害剤
• 世界の処方鎮痛薬市場、抗うつ薬、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• 選択的セロトニン再取り込み阻害薬
• 三環系抗うつ薬
• セロトニン・ノルエピネフリン再取り込み阻害剤
• その他の抗うつ薬
• 世界の処方鎮痛薬市場、その他のタイプ、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• 筋弛緩剤
• 局所鎮痛薬
• コルチコステロイド

第7章 地域別・国別分析

• 世界の処方鎮痛薬市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の処方鎮痛薬市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 処方鎮痛薬市場：競合情勢
• 処方鎮痛薬市場：企業プロファイル
  • Mallinckrodt Public Limited Company Overview, Products and Services, Strategy and Financial Analysis
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson And Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Merck And Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Bayer AG
• Sanofi S.A.
• Bristol-Myers Squibb Company
• AstraZeneca plc
• Novartis International AG
• GlaxoSmithKline Public Limited Company
• Takeda Pharmaceutical Company Limited
• Eli Lilly And Company
• Teva Pharmaceutical Industries Ltd.
• Boehringer Ingelheim GmbH
• Mylan N.V.
• Sandoz, Inc
• Bausch Health Companies Inc.
• Purdue Pharma L.P.
• Endo International Plc

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 処方鎮痛薬市場2029：新たな機会を提供する国
• 処方鎮痛薬市場2029：新たな機会を提供するセグメント
• 処方鎮痛薬市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Prescription pain medication refers to drugs that are legally prescribed by a licensed healthcare provider to manage moderate to severe pain. These medications are stronger than over-the-counter (OTC) pain relievers and are used when pain cannot be sufficiently controlled with non-prescription options.

The main types of prescription pain medications include prescription non-steroidal anti-inflammatory drugs (NSAIDs), opioids, anti-epileptic medications, antidepressants, and other types. Prescription NSAIDs are medications prescribed by healthcare professionals to reduce inflammation, relieve pain, and lower fever by inhibiting cyclooxygenase (COX) enzymes. These medications can be administered through various routes, such as oral, injectable, transdermal, and others. They are used to treat a wide range of conditions, including neuropathic pain, cancer pain, post-operative pain, and more. These drugs are distributed through various channels, including hospital pharmacies, retail pharmacies, and online pharmacies.

The prescription pain medications market research report is one of a series of new reports from The Business Research Company that provides prescription pain medications market statistics, including the prescription pain medications industry's global market size, regional shares, competitors with the prescription pain medications market share, detailed prescription pain medications market segments, market trends and opportunities, and any further data you may need to thrive in the prescription pain medications market. This prescription pain medications market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The prescription pain medication market size has grown strongly in recent years. It will grow from $73.59 billion in 2024 to $77.97 billion in 2025 at a compound annual growth rate (CAGR) of 5.9%. The growth during the historic period can be attributed to factors such as the increasing prevalence of chronic pain, a rising number of surgical procedures, a growing focus on palliative care, and an increase in musculoskeletal disorders.

The prescription pain medication market size is expected to see strong growth in the next few years. It will grow to $97.23 billion in 2029 at a compound annual growth rate (CAGR) of 5.7%. In the forecast period, growth is expected to be driven by factors such as the increasing demand for personalized medicine, a growing focus on post-traumatic pain management, greater adoption of telemedicine for pain management, a rising number of patients seeking opioid alternatives, and an increasing prevalence of neuropathic pain. Key trends during this period include the development of non-opioid pain alternatives, the integration of digital health solutions, innovation in targeted pain therapies, the development of combination pain medications, and advancements in non-addictive pain medications.

The growing prevalence of arthritis is expected to drive the expansion of the prescription pain medication market. Arthritis, which causes inflammation in one or more joints, leads to pain, swelling, stiffness, and reduced mobility. The rising prevalence of arthritis is largely attributed to obesity, as excess weight places additional stress on joints, especially the knees, and promotes inflammation. Prescription pain medications help manage arthritis by reducing inflammation and pain, improving joint function, and enhancing the overall quality of life for those affected. For example, in March 2023, the Office for Health Improvement and Disparities, a UK-based government department, reported that in 2022, 17.6% of people aged 16 and older had arthritis or an ongoing back or joint problem, up from 17.0% in 2021. As a result, the increasing prevalence of arthritis is driving growth in the prescription pain medication market.

Companies in the prescription pain medication market are focusing on developing alternative therapies, such as non-opioid painkillers, in response to growing concerns about opioid addiction and patient safety. Non-opioid painkillers provide pain relief without the addictive risks of opioids, offering safer and more effective long-term pain management solutions while reducing the potential for addiction and overdose. For instance, in January 2025, Vertex Pharmaceuticals Incorporated, a US-based biotechnology company, received approval from the U.S. Food and Drug Administration (FDA) for JOURNAVX, a first-in-class non-opioid oral medication. This medication selectively blocks NaV1.8 sodium channels in peripheral nerves to inhibit pain signals without affecting the central nervous system, offering effective acute pain relief without the risk of addiction. It has shown clinically meaningful pain reduction in Phase 3 trials for abdominoplasty and bunionectomy with a twice-daily dosing regimen, and it is not classified as a controlled substance, addressing the need for safer acute pain management.

In October 2022, Pfizer Inc., a US-based pharmaceutical company, acquired Biohaven Pharmaceuticals for $11.6 billion. This acquisition allows Pfizer to strengthen and expand its migraine treatment portfolio, accelerate the commercialization of innovative therapies, and enhance its internal medicine pipeline for sustained growth. Biohaven Pharmaceuticals, a US-based biopharmaceutical company, manufactures prescription pain medications.

Major players in the prescription pain medication market are Mallinckrodt Public Limited Company, Pfizer Inc., Johnson And Johnson, Merck And Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Novartis International AG, GlaxoSmithKline Public Limited Company, Takeda Pharmaceutical Company Limited, Eli Lilly And Company, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, Mylan N.V., Sandoz, Inc, Bausch Health Companies Inc., Purdue Pharma L.P., Endo International Plc.

North America was the largest region in the prescription pain medication market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in prescription pain medication report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the prescription pain medication market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The prescription pain medication market consists of sales of acetaminophen, antidepressants, anticonvulsants, muscle relaxants, and biologic pain medications. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Prescription Pain Medication Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on prescription pain medication market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for prescription pain medication ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The prescription pain medication market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Prescription Non-Steroidal Anti-Inflammatory Drugs; Opioids; Anti-Epileptic Medicines; Antidepressants; Other Types
• 2) By Route Of Administration: Oral; Injectable; Transdermal; Other Route Of Administrations
• 3) By Application: Neuropathic Pain; Cancer Pain; Post-Operative Pain; Other Applications
• 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• Subsegments:
• 1) By Prescription Non-Steroidal Anti-Inflammatory Drugs: COX-2 Inhibitors; Traditional Non-Steroidal Anti-Inflammatory Drugs; Combination Non-Steroidal Anti-Inflammatory Drugs
• 2) By Opioids: Strong Opioids; Mild Opioids; Opioid Combination Medications
• 3) By Anti-Epileptic Medicines: Sodium Channel Blockers; Gamma-Aminobutyric Acid Modulators; Glutamate Inhibitors
• 4) By Antidepressants: Selective Serotonin Reuptake Inhibitors; Tricyclic Antidepressants; Serotonin-Norepinephrine Reuptake Inhibitors; Other Antidepressants
• 5) By Other Types: Muscle Relaxants; Topical Pain Medications; Corticosteroids
• Companies Mentioned: Mallinckrodt Public Limited Company; Pfizer Inc.; Johnson And Johnson; Merck And Co. Inc.; AbbVie Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Prescription Pain Medication Market Characteristics

3. Prescription Pain Medication Market Trends And Strategies

4. Prescription Pain Medication Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Prescription Pain Medication Growth Analysis And Strategic Analysis Framework

• 5.1. Global Prescription Pain Medication PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Prescription Pain Medication Market Growth Rate Analysis
• 5.4. Global Prescription Pain Medication Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Prescription Pain Medication Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Prescription Pain Medication Total Addressable Market (TAM)

6. Prescription Pain Medication Market Segmentation

• 6.1. Global Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Prescription Non-Steroidal Anti-Inflammatory Drugs
• Opioids
• Anti-Epileptic Medicines
• Antidepressants
• Other Types
• 6.2. Global Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Injectable
• Transdermal
• Other Route Of Administrations
• 6.3. Global Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Neuropathic Pain
• Cancer Pain
• Post-Operative Pain
• Other Applications
• 6.4. Global Prescription Pain Medication Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 6.5. Global Prescription Pain Medication Market, Sub-Segmentation Of Prescription Non-Steroidal Anti-Inflammatory Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• COX-2 Inhibitors
• Traditional Non-Steroidal Anti-Inflammatory Drugs
• Combination Non-Steroidal Anti-Inflammatory Drugs
• 6.6. Global Prescription Pain Medication Market, Sub-Segmentation Of Opioids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Strong Opioids
• Mild Opioids
• Opioid Combination Medications
• 6.7. Global Prescription Pain Medication Market, Sub-Segmentation Of Anti-Epileptic Medicines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sodium Channel Blockers
• Gamma-Aminobutyric Acid Modulators
• Glutamate Inhibitors
• 6.8. Global Prescription Pain Medication Market, Sub-Segmentation Of Antidepressants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Selective Serotonin Reuptake Inhibitors
• Tricyclic Antidepressants
• Serotonin-Norepinephrine Reuptake Inhibitors
• Other Antidepressants
• 6.9. Global Prescription Pain Medication Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Muscle Relaxants
• Topical Pain Medications
• Corticosteroids

7. Prescription Pain Medication Market Regional And Country Analysis

• 7.1. Global Prescription Pain Medication Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Prescription Pain Medication Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Prescription Pain Medication Market

• 8.1. Asia-Pacific Prescription Pain Medication Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Prescription Pain Medication Market

• 9.1. China Prescription Pain Medication Market Overview
• 9.2. China Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Prescription Pain Medication Market

• 10.1. India Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Prescription Pain Medication Market

• 11.1. Japan Prescription Pain Medication Market Overview
• 11.2. Japan Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Prescription Pain Medication Market

• 12.1. Australia Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Prescription Pain Medication Market

• 13.1. Indonesia Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Prescription Pain Medication Market

• 14.1. South Korea Prescription Pain Medication Market Overview
• 14.2. South Korea Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Prescription Pain Medication Market

• 15.1. Western Europe Prescription Pain Medication Market Overview
• 15.2. Western Europe Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Prescription Pain Medication Market

• 16.1. UK Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Prescription Pain Medication Market

• 17.1. Germany Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Prescription Pain Medication Market

• 18.1. France Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Prescription Pain Medication Market

• 19.1. Italy Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Prescription Pain Medication Market

• 20.1. Spain Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Prescription Pain Medication Market

• 21.1. Eastern Europe Prescription Pain Medication Market Overview
• 21.2. Eastern Europe Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Prescription Pain Medication Market

• 22.1. Russia Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Prescription Pain Medication Market

• 23.1. North America Prescription Pain Medication Market Overview
• 23.2. North America Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Prescription Pain Medication Market

• 24.1. USA Prescription Pain Medication Market Overview
• 24.2. USA Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Prescription Pain Medication Market

• 25.1. Canada Prescription Pain Medication Market Overview
• 25.2. Canada Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Prescription Pain Medication Market

• 26.1. South America Prescription Pain Medication Market Overview
• 26.2. South America Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Prescription Pain Medication Market

• 27.1. Brazil Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Prescription Pain Medication Market

• 28.1. Middle East Prescription Pain Medication Market Overview
• 28.2. Middle East Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Prescription Pain Medication Market

• 29.1. Africa Prescription Pain Medication Market Overview
• 29.2. Africa Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Prescription Pain Medication Market Competitive Landscape And Company Profiles

• 30.1. Prescription Pain Medication Market Competitive Landscape
• 30.2. Prescription Pain Medication Market Company Profiles
  • 30.2.1. Mallinckrodt Public Limited Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Johnson And Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck And Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Prescription Pain Medication Market Other Major And Innovative Companies

• 31.1. Bayer AG
• 31.2. Sanofi S.A.
• 31.3. Bristol-Myers Squibb Company
• 31.4. AstraZeneca plc
• 31.5. Novartis International AG
• 31.6. GlaxoSmithKline Public Limited Company
• 31.7. Takeda Pharmaceutical Company Limited
• 31.8. Eli Lilly And Company
• 31.9. Teva Pharmaceutical Industries Ltd.
• 31.10. Boehringer Ingelheim GmbH
• 31.11. Mylan N.V.
• 31.12. Sandoz, Inc
• 31.13. Bausch Health Companies Inc.
• 31.14. Purdue Pharma L.P.
• 31.15. Endo International Plc

32. Global Prescription Pain Medication Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Prescription Pain Medication Market

34. Recent Developments In The Prescription Pain Medication Market

35. Prescription Pain Medication Market High Potential Countries, Segments and Strategies

• 35.1 Prescription Pain Medication Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Prescription Pain Medication Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Prescription Pain Medication Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer